Nguyen Minh T H, Imanishi Masaki, Li Shengyu, Chau Khanh, Banerjee Priyanka, Velatooru Loka Reddy, Ko Kyung Ae, Samanthapudi Venkata S K, Gi Young J, Lee Ling-Ling, Abe Rei J, McBeath Elena, Deswal Anita, Lin Steven H, Palaskas Nicolas L, Dantzer Robert, Fujiwara Keigi, Borchrdt Mae K, Turcios Estefani Berrios, Olmsted-Davis Elizabeth A, Kotla Sivareddy, Cooke John P, Wang Guangyu, Abe Jun-Ichi, Le Nhat-Tu
Center for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States.
Department of Life Science, Vietnam Academy of Science and Technology, University of Science and Technology of Hanoi, Hanoi, Vietnam.
Front Cardiovasc Med. 2023 Aug 30;10:1187490. doi: 10.3389/fcvm.2023.1187490. eCollection 2023.
The deSUMOylase sentrin-specific isopeptidase 2 (SENP2) plays a crucial role in atheroprotection. However, the phosphorylation of SENP2 at T368 under disturbed flow (D-flow) conditions hinders its nuclear function and promotes endothelial cell (EC) activation. SUMOylation has been implicated in D-flow-induced endothelial-to-mesenchymal transition (endoMT), but the precise role of SENP2 in counteracting this process remains unclear.
We developed a phospho-specific SENP2 S344 antibody and generated knock-in (KI) mice with a phospho-site mutation of SENP2 S344A using CRISPR/Cas9 technology. We then investigated the effects of SENP2 S344 phosphorylation under two distinct flow patterns and during hypercholesteremia (HC)-mediated EC activation.
Our findings demonstrate that laminar flow (L-flow) induces phosphorylation of SENP2 at S344 through the activation of checkpoint kinase 1 (CHK1), leading to the inhibition of ERK5 and p53 SUMOylation and subsequent suppression of EC activation. We observed a significant increase in lipid-laden lesions in both the aortic arch (under D-flow) and descending aorta (under L-flow) of female hypercholesterolemic SENP2 S344A KI mice. In male hypercholesterolemic SENP2 S344A KI mice, larger lipid-laden lesions were only observed in the aortic arch area, suggesting a weaker HC-mediated atherogenesis in male mice compared to females. Ionizing radiation (IR) reduced CHK1 expression and SENP2 S344 phosphorylation, attenuating the pro-atherosclerotic effects observed in female SENP2 S344A KI mice after bone marrow transplantation (BMT), particularly in L-flow areas. The phospho-site mutation SENP2 S344A upregulates processes associated with EC activation, including inflammation, migration, and proliferation. Additionally, fibrotic changes and up-regulated expression of EC marker genes were observed. Apoptosis was augmented in ECs derived from the lungs of SENP2 S344A KI mice, primarily through the inhibition of ERK5-mediated expression of DNA damage-induced apoptosis suppressor (DDIAS).
In this study, we have revealed a novel mechanism underlying the suppressive effects of L-flow on EC inflammation, migration, proliferation, apoptosis, and fibrotic changes through promoting CHK1-induced SENP2 S344 phosphorylation. The phospho-site mutation SENP2 S344A responds to L-flow through a distinct mechanism, which involves the upregulation of both mesenchymal and EC marker genes.
去SUMO化酶sentrin特异性异肽酶2(SENP2)在动脉粥样硬化保护中起关键作用。然而,在紊乱血流(D-flow)条件下,SENP2第368位苏氨酸(T368)的磷酸化会阻碍其核功能并促进内皮细胞(EC)活化。SUMO化与D-flow诱导的内皮-间充质转化(endoMT)有关,但SENP2在对抗这一过程中的精确作用仍不清楚。
我们开发了一种磷酸化特异性的SENP2 S344抗体,并使用CRISPR/Cas9技术构建了SENP2 S344A磷酸化位点突变的敲入(KI)小鼠。然后,我们研究了在两种不同血流模式下以及高胆固醇血症(HC)介导的EC活化过程中SENP2 S344磷酸化的影响。
我们的研究结果表明,层流(L-flow)通过激活检查点激酶1(CHK1)诱导SENP2在S344位点的磷酸化,导致ERK5和p53 SUMO化的抑制以及随后EC活化的抑制。我们观察到雌性高胆固醇血症SENP2 S344A KI小鼠的主动脉弓(在D-flow下)和降主动脉(在L-flow下)中富含脂质的病变显著增加。在雄性高胆固醇血症SENP2 S344A KI小鼠中,仅在主动脉弓区域观察到更大的富含脂质的病变,这表明与雌性小鼠相比,雄性小鼠中HC介导的动脉粥样硬化发生较弱。电离辐射(IR)降低了CHK1表达和SENP2 S344磷酸化,减轻了雌性SENP2 S344A KI小鼠骨髓移植(BMT)后观察到的促动脉粥样硬化作用,特别是在L-flow区域。磷酸化位点突变SENP2 S344A上调了与EC活化相关的过程,包括炎症、迁移和增殖。此外,还观察到纤维化变化和EC标记基因表达上调。SENP2 S344A KI小鼠肺来源的EC中凋亡增加,主要是通过抑制ERK5介导的DNA损伤诱导凋亡抑制因子(DDIAS)的表达。
在本研究中,我们揭示了一种新机制,即L-flow通过促进CHK1诱导的SENP2 S344磷酸化来抑制EC炎症、迁移、增殖、凋亡和纤维化变化。磷酸化位点突变SENP2 S344A通过一种独特的机制对L-flow作出反应,该机制涉及间充质和EC标记基因的上调。